Logo

David Roth, Pilar de la Huerta

Mar 01, 2017

Sygnis has appointed David Roth as its new CFO. In this role, Roth will be in charge of financial strategy and accounting processes. Former CFO Pilar de la Huerta will remain with the company, serving as co-CEO with Heikki Lanckriet and as chief business development officer. Roth comes to Sygnis with over 20 years of financial management experience focused on the healthcare sector, and has spent the last several years serving as CFO for several international organizations.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.